United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar HardnoseDotCom (73.45) Submitted: 4/25/2011 1:31:30 PM : Outperform Start Price: $69.52 UTHR Score: -35.51

low PEG, strong price uptrend

Featured Broker Partners


Advertisement